MAGNESIUM for Atrial fibrillation: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 15 adverse event reports in the FDA FAERS database where MAGNESIUM was used for Atrial fibrillation.
Most Reported Side Effects for MAGNESIUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 2,160 | 22.2% | 605 | 1,343 |
| Off label use | 1,502 | 15.4% | 589 | 1,115 |
| Maternal exposure during pregnancy | 1,227 | 12.6% | 484 | 628 |
| Pain | 1,098 | 11.3% | 510 | 837 |
| Nausea | 1,084 | 11.1% | 496 | 840 |
| Dyspnoea | 961 | 9.9% | 487 | 764 |
| Product use in unapproved indication | 949 | 9.7% | 496 | 578 |
| Condition aggravated | 926 | 9.5% | 519 | 747 |
| Vomiting | 912 | 9.4% | 509 | 645 |
| Diarrhoea | 900 | 9.2% | 417 | 554 |
| Foetal exposure during pregnancy | 876 | 9.0% | 81 | 220 |
| Headache | 820 | 8.4% | 356 | 676 |
| Infusion related reaction | 814 | 8.4% | 484 | 731 |
| Rash | 808 | 8.3% | 554 | 689 |
| Exposure during pregnancy | 794 | 8.2% | 244 | 396 |
Other Indications for MAGNESIUM
Product used for unknown indication (4,253)
Constipation (648)
Foetal exposure during pregnancy (327)
Pre-eclampsia (283)
Parenteral nutrition (243)
Nervous system disorder prophylaxis (212)
Prophylaxis (128)
Hypomagnesaemia (112)
Status epilepticus (107)
Ventricular tachycardia (93)
Other Drugs Used for Atrial fibrillation
RIVAROXABAN (52,584)
DABIGATRAN ETEXILATE (20,492)
APIXABAN (10,500)
AMIODARONE (9,083)
WARFARIN (8,680)
EDOXABAN (3,855)
ASPIRIN (2,993)
DOFETILIDE (2,439)
PRADAXA (2,325)
METOPROLOL (1,542)